Siemens Healthineers and Alibaba DAMO Academy Partner on Medical AI CT Screening
Siemens Healthineers and Alibaba DAMO Academy signed a strategic agreement at the 9th China International Import Expo to integrate Alibaba's AI-powered 'multi-disease CT screening' technology with medical imaging devices. This partnership aims to promote the early detection of major diseases such as cancers and cardiovascular conditions through a single CT scan. This collaboration represents a major translational milestone for medical AI research, bridging advanced algorithm development with mainstream clinical imaging infrastructure. By embedding DAMO Academy's AI into Siemens Healthineers' systems, hospitals can more efficiently screen for fatal diseases at early stages, potentially improving patient survival rates on a global scale. The partnership will integrate DAMO Academy's medical AI models to detect hard-to-spot lesions for cancers like pancreatic, gastric, colorectal, esophageal, and liver cancer, alongside acute cardiovascular conditions like aortic dissection. Furthermore, the partners will conduct joint clinical research with top institutions like Ruijin Hospital using cutting-edge photon-counting CT to detect even finer early lesions at lower radiation doses.
## BACKGROUND
Plain-scan CT is a widely used, rapid diagnostic tool in hospitals, but detecting subtle early-stage tumors or vascular lesions from these scans is historically difficult for human doctors without specialized AI assistance. Alibaba DAMO Academy's 'multi-disease CT screening' technology uses artificial intelligence to analyze these routine scans, having previously broken through major medical imaging hurdles and earned regulatory recognitions such as FDA Breakthrough Device designation. Photon-counting CT is a revolutionary imaging technology that uses semiconductor detectors to perform direct conversions of X-rays into electrical signals, enabling precise counting of individual photons and energy determination.